The Mechanism by which the Phenothiazine Thioridazine Contributes to Cure Problematic Drug-Resistant Forms of Pulmonary Tuberculosis: Recent Patents for “New Use”

By  

Recent Patents on Anti-Infective Drug Discovery, Vol. 8, Iss. 3, 2013-01 ,pp. : 206-212

Bentham Science Publishers

Access to resources Recommend Favorite

New Patentable Use of an Old Neuroleptic Compound Thioridazine to Combat Tuberculosis: A Gene Regulation Perspective

By  

Recent Patents on Anti-Infective Drug Discovery, Vol. 6, Iss. 2, 2011-05 ,pp. : 128-138

Bentham Science Publishers

Access to resources Recommend Favorite

The use of TNF-α blockers in psoriatic arthritis patients with latent tuberculosis infection

By Atteno Mariangela   Costa Luisa   Matarese Alessandro   Caso Francesco   Puente Antonio   Cantarini Luca   Bocchino Maria   Sanduzzi Alessandro   Scarpa Raffaele  

Clinical Rheumatology, Vol. 33, Iss. 4, 2014-04 ,pp. : 543-547

Springer Publishing Company

Access to resources Recommend Favorite

The Role of DOTS in Tuberculosis Treatment and Control

By Davies P.D.O.  

American Journal of Respiratory Medicine, Vol. 2, Iss. 3, 2003-01 ,pp. : 203-209

Adis International

Access to resources Recommend Favorite

Comparison of T-Cell Interferon- Release Assays for Mycobacterium tuberculosis -Specific Antigens in Patients with Active and Latent Tuberculosis

By Kobashi Yoshihiro  

Lung, Vol. 188, Iss. 4, 2010-08 ,pp. : 283-287

Springer Publishing Company

Access to resources Recommend Favorite